GENE-THERAPY STRATEGIES FOR TREATING NEOPLASTIC DISEASE

被引:7
作者
HUBER, BE
机构
[1] Wellcome Research Laboratories, North Carolina, 27709, 3030 Cornwallis Road, Research Triangle Park
来源
GENE THERAPY FOR NEOPLASTIC DISEASES | 1994年 / 716卷
关键词
D O I
10.1111/j.1749-6632.1994.tb21699.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:6 / 11
页数:6
相关论文
共 7 条
[1]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[2]   TARGETED GENE MODIFICATION FOR GENE-THERAPY OF STEM-CELLS [J].
BOGGS, SS .
INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (02) :80-96
[3]   ALTERING THE GENOME BY HOMOLOGOUS RECOMBINATION [J].
CAPECCHI, MR .
SCIENCE, 1989, 244 (4910) :1288-1292
[4]  
CASEY G, 1991, ONCOGENE, V6, P1791
[5]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[6]  
JOHNSON P, 1991, MOL CELL BIOL, V11, P1
[7]   INACTIVATING THE BETA-2-MICROGLOBULIN LOCUS IN MOUSE EMBRYONIC STEM-CELLS BY HOMOLOGOUS RECOMBINATION [J].
KOLLER, BH ;
SMITHIES, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8932-8935